[Microalgae as cell factories producing recombinant commercial proteins].
Extraction of natural substances and chemical synthesis are the main sources of pharmaceutical molecules. When possible, one may transfer the gene of the molecule in living cells creating individual factories producing on demand and in a safe way the requested molecule. Today, bacteria, yeast, mammalian cells and plants constitute the main plate-forms for various commercial products. Microalgae present numerous advantages and could offer a powerful tool for the production of commercial molecules in a near future.
Cadoret
Jean-Paul
JP
Laboratoire PBA, IFREMER, Centre de Nantes, rue de l'Ile d'Yeu, BP 21105, 44311 Nantes Cedex 03, France. jean.paul.cadoret@ifremer.fr
Bardor
Muriel
M
Lerouge
Patrice
P
Cabigliera
Morgan
M
Henriquez
Vitalia
V
Carlier
Aude
A
D000818:Animals; D002736:Chloroplasts / Q000502:physiology; D003132:Commerce; D056890:Eukaryota / Q000235:genetics / Q000502:physiology*; D020868:Gene Silencing; D051379:Mice; D008822:Mice, Transgenic; D008954:Models, Biological; D011506:Proteins / Q000235:genetics*; D011994:Recombinant Proteins / Q000096:biosynthesis*
D011506:Proteins; D011994:Recombinant Proteins